Benzinga | Nov 5, 2021 09:38AM EDT

SVB Leerink Maintains Outperform on Insulet, Raises Price Target to $350

SVB Leerink analyst Danielle Antalffy maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $300 to $350.